everybody's e-mail and i suggest you look at the information but the bridge hiv research unit is an nih clinic trials unit for hiv vaccines and for adolescent trials and the covid prevention network which is relatively new. we were given information on use and prep is high but discontinuation rates and the retention of those using prep after initiation is 38%. so that is part of the continuing work. we were also given information on two apps being piloted. one is prep mate a two-way texting support tool. it was developed with d.p.h. being pilot up locals and an individual app it's not a two-way like prep mate. they're researching both and comparing the apps and seeing whether both would be a good idea. we'll have more data going forward. there was a presentation on prep 3-d where pharmacists are now able to prescribe prep making the access much easier. the last part of the presentation was an update on multiple studies that the hiv unit is participating on. and updated slides were sent to you all via e-mail. the second part of our meeting was the housing conserve a conservator update and with the criteria